{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:49:56Z","timestamp":1791348596729,"version":"4.3.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xphs.2026.104493","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:43:57Z","timestamp":1788331437000},"page":"104493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of surfactants on the stability of therapeutic peptides under interfacial stress"],"prefix":"10.1016","volume":"115","author":[{"given":"Naomi","family":"Hamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8384-058X","authenticated-orcid":false,"given":"W.Peter","family":"Wuelfing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5063-3218","authenticated-orcid":false,"given":"Yongchao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2026.104493_bib0001","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1208\/s12248-014-9688-2","article-title":"Physicochemical and formulation developability assessment for therapeutic peptide delivery\u2014a primer","volume":"17","author":"Bak","year":"2015","journal-title":"AAPS J"},{"issue":"6","key":"10.1016\/j.xphs.2026.104493_bib0002","doi-asserted-by":"crossref","DOI":"10.1098\/rsfs.2017.0030","article-title":"Factors affecting the physical stability (aggregation) of peptide therapeutics","volume":"7","author":"Zapadka","year":"2017","journal-title":"Interface Focus"},{"key":"10.1016\/j.xphs.2026.104493_bib0003","article-title":"Evaluating surfactant effectiveness in preventing antibody adsorption directly on medical surfaces using a novel device","volume":"205","author":"\u00c1lvarez-Palencia Jim\u00e9nez","year":"2024","journal-title":"Eur J Pharm Biopharms"},{"issue":"12","key":"10.1016\/j.xphs.2026.104493_bib0004","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1016\/j.xphs.2022.09.004","article-title":"Exploring the protein stabilizing capability of surfactants against agitation stress and the underlying mechanisms","volume":"111","author":"Zoeller","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104493_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124374","article-title":"Effect of surfactants on lactate dehydrogenase aqueous solutions: a comparative study of poloxamer 188, polysorbate 20 and 80","volume":"661","author":"Li","year":"2024","journal-title":"Int J Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2026.104493_bib0006","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1021\/acs.molpharmaceut.3c00312","article-title":"Role of Poloxamer 188 in preventing ice-surface-induced protein destabilization during freeze\u2013Thawing","volume":"20","author":"Li","year":"2023","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2026.104493_bib0007","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jps.20365","article-title":"Effects of Tween 20\u00ae and Tween 80\u00ae on the stability of albutropin during agitation","volume":"94","author":"Chou","year":"2005","journal-title":"J Pharm Sci"},{"issue":"13","key":"10.1016\/j.xphs.2026.104493_bib0008","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.addr.2011.06.015","article-title":"Molecular origins of surfactant-mediated stabilization of protein drugs","volume":"63","author":"Lee","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"10.1016\/j.xphs.2026.104493_bib0009","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jps.23908","article-title":"Protein effects on surfactant adsorption suggest the dominant mode of surfactant-mediated stabilization of protein","volume":"103","author":"Kim","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104493_bib0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejpb.2015.09.016","article-title":"Key interactions of surfactants in therapeutic protein formulations: a review","volume":"97","author":"Khan","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"issue":"12","key":"10.1016\/j.xphs.2026.104493_bib0011","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1021\/js980175v","article-title":"Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions","volume":"87","author":"Bam","year":"1998","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104493_bib0012","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00249-009-0404-6","article-title":"Insights into protein\u2013polysorbate interactions analysed by means of isothermal titration and differential scanning calorimetry","volume":"38","author":"Hoffmann","year":"2009","journal-title":"Eur Biophys J"},{"issue":"3","key":"10.1016\/j.xphs.2026.104493_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/psc.70001","article-title":"Regulatory guidelines for the analysis of therapeutic peptides and proteins","volume":"31","author":"Elsayed","year":"2025","journal-title":"J Pept Sci"},{"key":"10.1016\/j.xphs.2026.104493_bib0014","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fendo.2019.00155","article-title":"The discovery and development of liraglutide and semaglutide","volume":"10","author":"Knudsen","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.xphs.2026.104493_bib0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1021\/acs.bioconjchem.4c00484","article-title":"Effect of lipidation on the structure, oligomerization, and aggregation of glucagon-like peptide 1","volume":"36","author":"P\u0159\u00e1da Brichtov\u00e1","year":"2025","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.xphs.2026.104493_bib0016","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/mp500519s","article-title":"Transformation of oligomers of lipidated peptide induced by change in pH","volume":"12","author":"Wang","year":"2015","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2026.104493_bib0017","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.bpj.2015.07.051","article-title":"Oligomerization of a glucagon-like peptide 1 analog: bridging experiment and simulations","volume":"109","author":"Frederiksen","year":"2015","journal-title":"Biophys J"},{"issue":"5","key":"10.1016\/j.xphs.2026.104493_bib0018","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1021\/acs.molpharmaceut.9b00106","article-title":"Peptide oligomerization memory effects and their impact on the physical stability of the GLP-1 agonist liraglutide","volume":"16","author":"Bothe","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2026.104493_bib0019","article-title":"Unveiling the hidden: dissecting liraglutide oligomerization dual pathways via direct mass technology, electron-capture dissociation, and molecular dynamics","author":"Kuo","year":"2025","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.xphs.2026.104493_bib0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jps.2600630136","article-title":"CMC of polysorbates","volume":"63","author":"Wan","year":"1974","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104493_bib0021","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1039\/c0sm00965b","article-title":"Molecular dynamics simulation of a polysorbate 80 micelle in water","volume":"7","author":"Amani","year":"2011","journal-title":"Soft Matter"},{"issue":"4","key":"10.1016\/j.xphs.2026.104493_bib0022","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.xphs.2019.12.016","article-title":"Micellar morphology of polysorbate 20 and 80 and their ester fractions in solution via small-angle neutron scattering","volume":"109","author":"Nayem","year":"2020","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104493_bib0023","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3109\/03639040903520983","article-title":"Synthesis and characterization of Poloxamer 188-grafted heparin copolymer","volume":"36","author":"Tian","year":"2010","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2026.104493_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121706","article-title":"Poloxamer 188 as surfactant in biological formulations \u2013 an alternative for polysorbate 20\/80?","volume":"620","author":"Bollenbach","year":"2022","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104493_bib0025","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.xphs.2022.09.019","article-title":"Micelle formation and phase separation of poloxamer 188 and preservative molecules in aqueous solutions studied by small angle X-ray scattering","volume":"112","author":"Ford","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104493_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.127119","article-title":"Interfacial and self-association behaviour of poloxamer 188 in aqueous solutions","volume":"424","author":"Bollenbach","year":"2025","journal-title":"J Mol Liq"},{"issue":"7","key":"10.1016\/j.xphs.2026.104493_bib0027","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41594-019-0238-6","article-title":"The peptide hormone glucagon forms amyloid fibrils with two coexisting beta-strand conformations","volume":"26","author":"Gelenter","year":"2019","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104493_bib0028","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14656566.7.3.325","article-title":"Insulin detemir: from concept to clinical experience","volume":"7","author":"Home","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.xphs.2026.104493_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114566","article-title":"Oligomerization, albumin binding and catabolism of therapeutic peptides in the subcutaneous compartment: an investigation on lipidated GLP-1 analogs","volume":"210","author":"Gallo","year":"2022","journal-title":"J Pharm Biomed Anal"},{"issue":"6","key":"10.1016\/j.xphs.2026.104493_bib0030","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1021\/acs.biomac.5c00342","article-title":"Semaglutide aggregates into oligomeric micelles and short fibrils in aqueous solution","volume":"26","author":"Hamley","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.xphs.2026.104493_bib0031","unstructured":"David Paul ALLEN, Brandon Lee Doyle, Ken Kangyi Qian, Evan Michael HETRICK. Preserved gip\/glp agonist compositions. WO2024086601A2. 2023"},{"issue":"7","key":"10.1016\/j.xphs.2026.104493_bib0032","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.tibtech.2014.05.005","article-title":"Therapeutic protein aggregation: mechanisms, design, and control","volume":"32","author":"Roberts","year":"2014","journal-title":"Trends Biotechnol."},{"issue":"3","key":"10.1016\/j.xphs.2026.104493_bib0033","article-title":"Antibody aggregation: insights from sequence and structure","volume":"5","author":"Li","year":"2016","journal-title":"Antibodies (Basel)"},{"issue":"1","key":"10.1016\/j.xphs.2026.104493_bib0034","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1432-1033.1969.tb00735.x","article-title":"Formation and structure of gels and fibrils from Glucagon","volume":"11","author":"Beaven","year":"1969","journal-title":"Eur J Biochem"},{"issue":"4","key":"10.1016\/j.xphs.2026.104493_bib0035","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jmb.2010.02.012","article-title":"Glucagon fibril polymorphism reflects differences in protofilament backbone structure","volume":"397","author":"Andersen","year":"2010","journal-title":"J Mol Biol"},{"key":"10.1016\/j.xphs.2026.104493_bib0036","unstructured":"Pohl, S.S.S.H.L.F. Stabilized glucagon solutions. US 2010."},{"issue":"11","key":"10.1016\/j.xphs.2026.104493_bib0037","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/dia.2014.0047","article-title":"Biochemical stabilization of glucagon at alkaline pH","volume":"16","author":"Caputo","year":"2014","journal-title":"Diabetes Technol Ther"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:52:28Z","timestamp":1791345148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022354926003436"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104493","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of surfactants on the stability of therapeutic peptides under interfacial stress","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104493"}}